AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Prestige BioPharma Limited

₩6130 -$7430.00 (-54.79%)
KSC · 14 Sep 2026 06:30 UTC
Previous Close
₩6190
Day Range
₩5960₩6260
Year Range
₩4945₩15110
Market Cap
368.39B
AVG Volume
75.89K
Trailing/Forward PE
-3.08/-
PEG ratio
0.04
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Korea ExchangeKR
Revenue (KRW)
-5B05B10B15B23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
950210.KS Revenue (KRW) by quarter
PeriodRevenue (KRW)
25 Q414.52B
25 Q3520.97M
25 Q27.87B
25 Q12.31B
24 Q45.51B
24 Q33.34B
24 Q23.11B
24 Q12.22B
23 Q4-137.09M
23 Q3638.62M
Net Income (KRW)
-50B-25B025B50B75B23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
950210.KS Net Income (KRW) by quarter
PeriodNet Income (KRW)
25 Q4-47.91B
25 Q3-21.04B
25 Q2-15.4B
25 Q1-12.34B
24 Q4-8.78B
24 Q350.46B
24 Q2-13.19B
24 Q1-5.78B
23 Q4-9.29B
23 Q3-1.44B
Operating Income (KRW)
-30B-20B-10B023 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
950210.KS Operating Income (KRW) by quarter
PeriodOperating Income (KRW)
25 Q4-22.44B
25 Q3-26.96B
25 Q2-19.08B
25 Q1-24.27B
24 Q4-14.27B
24 Q3-15.35B
24 Q2-21.97B
24 Q1-15.5B
23 Q4-9.74B
23 Q3-16.74B
EBITDA (KRW)
-40B-20B020B40B23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
950210.KS EBITDA (KRW) by quarter
PeriodEBITDA (KRW)
25 Q4-22.44B
25 Q3-18.31B
25 Q2-11.61B
25 Q1-16.6B
24 Q42.58B
24 Q3-11.28B
24 Q2-17.91B
24 Q120.5B
23 Q4-5.13B
23 Q3-13.83B
Cash Flows (KRW)
-40B-30B-20B-10B023 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
950210.KS Cash Flows (KRW) by quarter
PeriodCash Flows (KRW)
25 Q3-14.74B
25 Q2-12.53B
25 Q1-18.16B
24 Q4-13.92B
24 Q3-24.04B
24 Q2-21.93B
24 Q1-34.98B
23 Q4-20.14B
23 Q3-17.78B
23 Q2-17.76B
EPS (KRW)
-2000-10000100023 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
950210.KS EPS (KRW) by quarter
PeriodEPS (KRW)
25 Q4-1181.75
25 Q3-350.04
25 Q2-256.19
25 Q1-205
24 Q4-146.02
24 Q3838.4
24 Q2-223.2
24 Q1-96.26
23 Q4-154.51
23 Q3-23.93
Expenses (KRW)
-50B-25B025B50BR&DSG&ACapex23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
950210.KS Expenses (KRW) by quarter
PeriodExpenses (KRW)
23 Q26.24B
25 Q40
25 Q316.65B
25 Q210.62B
25 Q144.43B
24 Q4-26.92B
24 Q345.63B
24 Q228.04B
24 Q137.72B
23 Q4-21.61B
23 Q319.95B
Cash & Debt (KRW)
0100B200B300BCashLong Term DebtShort Term Debt23 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
950210.KS Cash & Debt (KRW) by quarter
PeriodCash & Debt (KRW)
25 Q365.89B
25 Q285.26B
25 Q1134.81B
24 Q4173.13B
24 Q3213.27B
24 Q2242.88B
24 Q1225.76B
23 Q4228.81B
23 Q3243.14B
23 Q2102B
Debt ratios
-100102023 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
950210.KS Debt ratios by quarter
PeriodDebt ratios
25 Q3-0.46
25 Q20
25 Q10.18
24 Q44.86
24 Q34.69
24 Q25.83
24 Q118.39
23 Q43.62
23 Q3-8.77
23 Q2-1.33
Margins
-3000%-2000%-1000%0%1000%23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
950210.KS Margins by quarter
PeriodMargins
25 Q40%
25 Q3-2301.16%
25 Q2-125.2%
25 Q15.52%
24 Q4-226.95%
24 Q3100%
24 Q2100%
24 Q1100%
23 Q4988.37%
23 Q3100%
Return on Capital
-5%0%5%10%23 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
950210.KS Return on Capital by quarter
PeriodReturn on Capital
25 Q3-3.75%
25 Q2-3.18%
25 Q1-2.47%
24 Q4-1.74%
24 Q39.33%
24 Q2-2.67%
24 Q1-1.18%
23 Q4-1.8%
23 Q3-0.28%
23 Q2-2.54%
Shares Outstanding
020M40M60M80M23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
950210.KS Shares Outstanding by quarter
PeriodShares Outstanding
25 Q460.1M
25 Q360.1M
25 Q260.1M
25 Q160.17M
24 Q460.1M
24 Q360.19M
24 Q259.08M
24 Q160.1M
23 Q460.1M
23 Q360.1M
Book Value Per Share (KRW)
02500500075001000023 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
950210.KS Book Value Per Share (KRW) by quarter
PeriodBook Value Per Share (KRW)
25 Q39341.16
25 Q28061.51
25 Q18298.26
24 Q48415.92
24 Q38989.65
24 Q28351.86
24 Q18129.43
23 Q48577.97
23 Q38585.47
23 Q28502.29
Total Assets (KRW)
0200B400B600B800B23 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
950210.KS Total Assets (KRW) by quarter
PeriodTotal Assets (KRW)
25 Q3775.71B
25 Q2668.46B
25 Q1714.76B
24 Q4741.92B
24 Q3793.96B
24 Q2756.46B
24 Q1716.65B
23 Q4711.72B
23 Q3710.29B
23 Q2701.46B
PE Ratio
2030405060med 35.84Nov 23Jul 25Sep 25Nov 25Feb 26Apr 26Jun 26
950210.KS PE Ratio by quarter
PeriodPE Ratio
Jun 2625.45
Jun 2628.38
Jun 2629.97
Jun 2629.24
May 2629.84
May 2633.59
May 2633.5
May 2634.45
Apr 2638.37
Apr 2639.7
Apr 2642.8
Apr 2639.36
Apr 2641.34
Mar 2638.26
Mar 2636.03
Mar 2636.25
Mar 2637.26
Feb 2639.64
Feb 2643.77
Feb 2644.59
Feb 2643.36
Jan 2642.06
Jan 2642.92
Jan 2644.78
Jan 2648.09
Jan 2650.47
Dec 2532.67
Dec 2534.52
Dec 2534.18
Dec 2536.16
Nov 2534.66
Nov 2531.38
Nov 2533.28
Nov 2531.53
Oct 2532.99
Oct 2532.8
Oct 2533.7
Oct 2534.05
Oct 2534.44
Sep 2536.35
Sep 2539.82
Sep 2539.79
Sep 2540.03
Aug 2537.13
Aug 2537.59
Aug 2542.61
Aug 2539.76
Aug 2537.97
Jul 2541.01
Jul 2543.64
Jul 2549.95
Jul 2550.6
Dec 2331.94
Dec 2331.53
Dec 2331.7
Dec 2332.11
Dec 2333.22
Nov 2333.99
Nov 2333.65
Nov 2333.49
Nov 2333.82
Oct 2333.79
Oct 2333.76
Oct 2335.84
Oct 2334.09
Free Cash Flow Yield
-20%-15%-10%-5%med -12.02%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
950210.KS Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-15.95%
Sep 26-15.19%
Aug 26-15.36%
Aug 26-16.27%
Aug 26-13.72%
Aug 26-14.96%
Jul 26-15.43%
Jul 26-18.81%
Jul 26-18.67%
Jul 26-17.14%
Jul 26-16.32%
Jun 26-19.33%
Jun 26-17.33%
Jun 26-16.41%
Jun 26-16.82%
May 26-16.48%
May 26-14.65%
May 26-14.68%
May 26-14.28%
Apr 26-12.82%
Apr 26-12.39%
Apr 26-11.49%
Apr 26-12.5%
Apr 26-11.9%
Mar 26-12.62%
Mar 26-13.4%
Mar 26-13.32%
Mar 26-12.96%
Feb 26-12.18%
Feb 26-11.03%
Feb 26-10.83%
Feb 26-11.14%
Jan 26-11.48%
Jan 26-11.25%
Jan 26-10.78%
Jan 26-10.04%
Jan 26-9.57%
Dec 25-12.78%
Dec 25-12.1%
Dec 25-12.22%
Dec 25-11.55%
Nov 25-12.05%
Nov 25-13.31%
Nov 25-12.55%
Nov 25-13.24%
Oct 25-12.66%
Oct 25-12.73%
Oct 25-12.39%
Oct 25-12.27%
Oct 25-12.13%
Sep 25-12.53%
Sep 25-11.43%
Sep 25-11.44%
Sep 25-11.37%
Aug 25-12.26%
Aug 25-12.11%
Aug 25-10.68%
Aug 25-11.45%
Aug 25-11.99%
Jul 25-11.1%
Jul 25-10.43%
Jul 25-9.11%
Jul 25-9%
Jun 25-13.52%
Jun 25-13.29%
Jun 25-13.05%
Jun 25-12.1%
May 25-12.12%
May 25-12.2%
May 25-12.07%
May 25-11.91%
May 25-11.36%
Apr 25-10.5%
Apr 25-10.84%
Apr 25-11.03%
Apr 25-11.75%
Mar 25-11.33%
Mar 25-12.79%
Mar 25-11%
Mar 25-11.32%
Feb 25-11.04%
Feb 25-10.31%
Feb 25-9.96%
Feb 25-9.9%
Jan 25-10.38%
Jan 25-10%
Jan 25-9.75%
Jan 25-9.83%
Jan 25-9.66%
Dec 24-8.91%
Dec 24-8.79%
Dec 24-8.32%
Dec 24-8.52%
Nov 24-8.97%
Nov 24-8.58%
Nov 24-7.71%
Nov 24-7.03%
Nov 24-7.36%
Oct 24-7.16%
Oct 24-8.49%
Price to Sales
0500100015002000med 76.2Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
950210.KS Price to Sales by quarter
PeriodPrice to Sales
Sep 2622.94
Sep 2624.09
Aug 2623.83
Aug 2622.49
Aug 2626.68
Aug 2624.46
Jul 2623.72
Jul 2619.46
Jul 2619.6
Jul 2621.35
Jul 2622.42
Jun 2618.66
Jun 2620.8
Jun 2621.97
Jun 2621.44
May 2621.88
May 2624.62
May 2624.56
May 2625.26
Apr 2628.13
Apr 2629.11
Apr 2631.38
Apr 2628.85
Apr 2630.31
Mar 2643.32
Mar 2640.8
Mar 2641.05
Mar 2642.19
Feb 2644.88
Feb 2649.56
Feb 2650.49
Feb 2649.1
Jan 2647.62
Jan 2648.59
Jan 2650.7
Jan 2654.45
Jan 2657.15
Dec 2552.3
Dec 2555.26
Dec 2554.71
Dec 2557.89
Nov 2555.47
Nov 2550.22
Nov 2553.27
Nov 2550.48
Oct 2552.81
Oct 2552.51
Oct 2553.95
Oct 2554.5
Oct 2555.14
Sep 2594.52
Sep 25103.54
Sep 25103.47
Sep 25104.11
Aug 2596.56
Aug 2597.76
Aug 25110.8
Aug 25103.4
Aug 2598.75
Jul 25106.64
Jul 25113.48
Jul 25129.9
Jul 25131.59
Jun 25120.12
Jun 25122.24
Jun 25124.47
Jun 25134.28
May 25134.08
May 25133.17
May 25134.59
May 25136.41
May 25142.98
Apr 25154.72
Apr 25149.87
Apr 25147.23
Apr 25138.23
Mar 25281.55
Mar 25249.42
Mar 25290.01
Mar 25281.77
Feb 25288.95
Feb 25309.24
Feb 25320.24
Feb 25322.14
Jan 25307.34
Jan 25318.76
Jan 25327
Jan 25324.25
Jan 25329.96
Dec 241239
Dec 241256.45
Dec 241326.26
Dec 241295.72
Nov 241231.15
Nov 241286.99
Nov 241432.71
Nov 241570.57
Nov 241500.76
Oct 241540.9
Oct 241300.08
EV/EBITDA
050100150med 39.33Oct 23Dec 23Feb 24Apr 24Jun 24Aug 24Sep 24
950210.KS EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2438.73
Sep 2441.38
Sep 2437.1
Sep 2434.69
Aug 2439.21
Aug 2437.1
Aug 2444.78
Aug 2438.02
Aug 2434.11
Jul 2437.98
Jul 2431.66
Jul 2423.64
Jul 2422.46
Jun 2442.77
Jun 2444.04
Jun 2444.4
Jun 2443.12
May 2439.2
May 2437.87
May 2439.71
May 2439.55
May 2439.96
Apr 2439.45
Apr 2439.6
Apr 2440.47
Apr 2442.71
Mar 24129.45
Mar 24129.21
Mar 24123.11
Mar 24120.29
Feb 24122.87
Feb 24122.87
Feb 24119.12
Feb 24110.9
Feb 24112.54
Jan 24112.31
Jan 24127.1
Jan 24140.95
Jan 24144.7
Dec 235.1
Dec 235
Dec 235.04
Dec 235.14
Dec 235.43
Nov 235.63
Nov 235.54
Nov 235.5
Nov 235.59
Oct 235.58
Oct 235.57
Oct 236.11
Oct 235.66
Price to Book
0.511.522.5med 1.54Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
950210.KS Price to Book by quarter
PeriodPrice to Book
Sep 260.66
Sep 260.7
Aug 260.69
Aug 260.65
Aug 260.77
Aug 260.71
Jul 260.69
Jul 260.56
Jul 260.57
Jul 260.62
Jul 260.65
Jun 260.73
Jun 260.82
Jun 260.86
Jun 260.84
May 260.86
May 260.97
May 260.97
May 260.99
Apr 261.11
Apr 261.14
Apr 261.23
Apr 261.13
Apr 261.19
Mar 261.24
Mar 261.17
Mar 261.17
Mar 261.21
Feb 261.28
Feb 261.42
Feb 261.44
Feb 261.4
Jan 261.36
Jan 261.39
Jan 261.45
Jan 261.56
Jan 261.63
Dec 251.47
Dec 251.55
Dec 251.54
Dec 251.62
Nov 251.56
Nov 251.41
Nov 251.49
Nov 251.42
Oct 251.48
Oct 251.47
Oct 251.51
Oct 251.53
Oct 251.55
Sep 251.49
Sep 251.63
Sep 251.63
Sep 251.64
Aug 251.52
Aug 251.54
Aug 251.75
Aug 251.63
Aug 251.56
Jul 251.68
Jul 251.79
Jul 252.05
Jul 252.08
Jun 251.42
Jun 251.45
Jun 251.47
Jun 251.59
May 251.59
May 251.58
May 251.59
May 251.61
May 251.69
Apr 251.83
Apr 251.77
Apr 251.74
Apr 251.64
Mar 251.64
Mar 251.45
Mar 251.69
Mar 251.64
Feb 251.68
Feb 251.8
Feb 251.86
Feb 251.87
Jan 251.79
Jan 251.85
Jan 251.9
Jan 251.89
Jan 251.92
Dec 241.66
Dec 241.68
Dec 241.77
Dec 241.73
Nov 241.64
Nov 241.72
Nov 241.91
Nov 242.1
Nov 242.01
Oct 242.06
Oct 241.74
Prestige BioPharma Limited
950210.KS
Stockpicker

Video analysis: 950210.KS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.